Envafolimab (ASC 22) is a humanized monoclonal antibody targeting programmed cell death ligand-1 (PD-L1), with antitumor activity. It blocks the interaction between PD-L1 and PD-1, and is used in studies of solid tumors.
Purity:
95.00%
CAS Number:
[2102192-68-5]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted